BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9310484)

  • 1. Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor for its interaction with endothelial cells.
    Perrault C; Lankhof H; Pidard D; Kerbiriou-Nabias D; Sixma JJ; Meyer D; Baruch D
    Blood; 1997 Sep; 90(6):2335-44. PubMed ID: 9310484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine treatment of endothelial cells increases glycoprotein Ib alpha-dependent adhesion to von Willebrand factor.
    Beacham DA; Tran LP; Shapiro SS
    Blood; 1997 Jun; 89(11):4071-7. PubMed ID: 9166847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor.
    Denis C; Williams JA; Lu X; Meyer D; Baruch D
    Blood; 1993 Dec; 82(12):3622-30. PubMed ID: 7505120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of alpha IIb beta 3 engagement.
    Mekrache M; Bachelot-Loza C; Ajzenberg N; Saci A; Legendre P; Baruch D
    Blood; 2003 Jun; 101(11):4363-71. PubMed ID: 12543870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
    Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
    J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal.
    Englund GD; Bodnar RJ; Li Z; Ruggeri ZM; Du X
    J Biol Chem; 2001 May; 276(20):16952-9. PubMed ID: 11278380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B; Houllier A; Meyer D; Girma JP
    Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand factor substratum.
    Beacham DA; Cruz MA; Handin RI
    Thromb Haemost; 1995 Feb; 73(2):309-17. PubMed ID: 7792748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor.
    Lankhof H; Wu YP; Vink T; Schiphorst ME; Zerwes HG; de Groot PG; Sixma JJ
    Blood; 1995 Aug; 86(3):1035-42. PubMed ID: 7620157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von Willebrand factor-endothelial cell interaction and inhibits angiogenesis.
    Yeh CH; Wang WC; Hsieh TT; Huang TF
    J Biol Chem; 2000 Jun; 275(25):18615-8. PubMed ID: 10779501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta).
    Bodnar RJ; Xi X; Li Z; Berndt MC; Du X
    J Biol Chem; 2002 Dec; 277(49):47080-7. PubMed ID: 12361948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
    Cranmer SL; Ulsemer P; Cooke BM; Salem HH; de la Salle C; Lanza F; Jackson SP
    J Biol Chem; 1999 Mar; 274(10):6097-106. PubMed ID: 10037692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor.
    Christophe O; Ribba AS; Baruch D; Obert B; Rouault C; Niinomi K; Piétu G; Meyer D; Girma JP
    Blood; 1994 Jun; 83(12):3553-61. PubMed ID: 8204881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction.
    Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.
    Depraetere H; Ajzenberg N; Girma JP; Lacombe C; Meyer D; Deckmyn H; Baruch D
    Blood; 1998 May; 91(10):3792-9. PubMed ID: 9573016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate.
    Keuren JF; Baruch D; Legendre P; Denis CV; Lenting PJ; Girma JP; Lindhout T
    Blood; 2004 Mar; 103(5):1741-6. PubMed ID: 14604963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib alpha using canine-human chimeras.
    Shen Y; Dong Jf JF; Romo GM; Arceneaux W; Aprico A; Gardiner EE; López JA; Berndt MC; Andrews RK
    Blood; 2002 Jan; 99(1):145-50. PubMed ID: 11756164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.